Basics |
Fortress Biotech, Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products.
|
IPO Date: |
December 1, 2011 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$57.37M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.08 | 3.64%
|
Avg Daily Range (30 D): |
$0.05 | 2.39%
|
Avg Daily Range (90 D): |
$0.05 | 2.71%
|
Institutional Daily Volume |
Avg Daily Volume: |
.41M |
Avg Daily Volume (30 D): |
.21M |
Avg Daily Volume (90 D): |
.19M |
Trade Size |
Avg Trade Size (Sh.): |
218 |
Avg Trade Size (Sh.) (30 D): |
230 |
Avg Trade Size (Sh.) (90 D): |
218 |
Institutional Trades |
Total Inst.Trades: |
36 |
Avg Inst. Trade: |
$2.41M |
Avg Inst. Trade (30 D): |
$1.09M |
Avg Inst. Trade (90 D): |
$1.09M |
Avg Inst. Trade Volume: |
.03M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.49M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
11.5K |
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-.48
|
$-.26
|
$-2.69
|
Diluted EPS
|
$-.48
|
$-.26
|
$-2.69
|
Revenue
|
$ 13.14M
|
$ 15.12M
|
$ 57.68M
|
Gross Profit
|
$ 8.35M
|
$ 12.88M
|
$ 36.8M
|
Net Income / Loss
|
$ -24.69M
|
$ -26.32M
|
$ -120.86M
|
Operating Income / Loss
|
$ -22.32M
|
$ -23.84M
|
$ -110.38M
|
Cost of Revenue
|
$ 4.79M
|
$ 2.24M
|
$ 20.88M
|
Net Cash Flow
|
$ 33.74M
|
$ -24.55M
|
$ -24.55M
|
PE Ratio
|
|
|
|
Splits |
Oct 10, 2023:
1:15
|
Dec 06, 2022:
1:10
|
|
|
|